IPP Bureau
Caplin Point Lab's subsidiary receives nod from Brazil's ANVISA for sterile injectable manufacturing site
By IPP Bureau - August 17, 2021
The approval allows it to market its products in the country
.jpg "Fortis Healthcare PAT at Rs 263.55 cr in Q1FY22")
Fortis Healthcare PAT at Rs 263.55 cr in Q1FY22
By IPP Bureau - August 16, 2021
It has initiated investments for advanced medical equipment such as Cath Labs, neuro microscopes, bone marrow transplant units at select facilities
Researchers develop remote ultrasound imaging using robotic technology
By IPP Bureau - August 16, 2021
The project is a collaboration between IIT Delhi and AIIMS
Aster DM Heathcare plans India expansion
By IPP Bureau - August 16, 2021
Investment of Rs 235 crores to add 411 beds in the next 18 months
IOL Chemicals and Pharma commissions Unit-10 for Rs 28.69 crores
By IPP Bureau - August 16, 2021
'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is expected to be complete in Q3FY22
Orchid Pharma reports net loss of Rs 30.90 cr in Q1FY22
By IPP Bureau - August 16, 2021
EPS for the period at Rs. (7.57)
Glenmark Pharmaceuticals net profit at Rs 306.52 crores in Q1FY22
By IPP Bureau - August 16, 2021
The company reports revenue growth of 26% and PAT growth of 21% YoY
Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
By IPP Bureau - August 16, 2021
The hospital chain aggressively embarks on digitisation and is e-health ready
.jpg "Antiviral face mask capable of inactivating COVID19")
Antiviral face mask capable of inactivating COVID19
By IPP Bureau - August 16, 2021
The antiviral technology involves the presence of active positive charges on the fabric, as binding sites for viruses and on contact with the fabric, virus cells that are negatively charged are neutralised, leading to the rapid destruction of their glycoprotein layers and the release of non-infectious ribonucleic acid (RNA)
Zydus Cadila receives final approval for Mesalamine extended-release capsules
By IPP Bureau - August 16, 2021
The group has a total of 320 ANDA approvals
Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation
By IPP Bureau - August 16, 2021
National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of the Quality Council of India, set up to establish and operate accreditation programmes for healthcare organisations
India restricts export of Rapid Antigen Test Kits used to detect Covid 19
By IPP Bureau - August 16, 2021
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
Apollo Hospitals inks MoU with Group of Hospitals for liver transplant
By IPP Bureau - August 14, 2021
The MoU was signed on World Organ Donation Day which falls on August 13
Bharat Biotech’s first nasal vaccine gets approval for Phase 2 trials
By IPP Bureau - August 14, 2021
This is the first of its kind vaccine for Covid 19 to get the go-ahead
